After approval by the ethics and research committee of Hamadan University of Medical Sciences and obtaining written informed consents from the participants, a total of 72 women (age range, 18 - 45 years), classified as ASA I-II with gestational age of > 37 weeks, were enrolled in this double-blind clinical trial. The parturients were scheduled for elective cesarean section under spinal anesthesia.
The exclusion criteria in the present study were as follows: (1) preeclampsia, (2) chronic hypertension, (3) diabetes, (4) allergy to drugs used in the study, (5) contraindication to neuraxial anesthesia, (6) blood pressure below 90 mmHg and heart rate (HR) below 50/min, (7) need for general anesthesia, (8) addiction or drug abuse, and (9) any unexpected accidents.
An 18-guage intravenous (IV) line was inserted and all the participants received 50 mg of IV ranitidine and 10 mg of IV metoclopramide at 1 hour before arrival in the operating room. Before the induction of spinal anesthesia, 300 mL of Ringer’s solution was infused, and baseline standard monitoring was performed in a supine position through automatic monitoring (Novin S1800, Saadat model).
Spinal anesthesia was induced by a 25-gauge Quincke needle (Mekon Medical Devices Co., Shanghai, China) at the L3-L4 interspace, parallel to the dural fiber, while the subject was in a sitting position. Spinal anesthesia consisted of 12.5 mg of hyperbaric bupivacaine 0.5% (2.5 mL; AstraZeneca, Austria) plus 5 µg (1 mL) of sufentanil (Sufiject Aburaihan Co., Iran), administered in 12 seconds.
The subjects were randomly allocated into 3 groups, using opaque envelopes (block randomization with a block size of 9): groups S1 and S2 in which the subjects remained in a sitting position for 1 and 2 minutes, respectively after the induction of spinal anesthesia, and group T which was immediately placed in a lying position. A 15° head-down tilt was then performed in all 3 groups. Considering the blind design of the study, an anesthesiologist administered the spinal anesthetic and randomized the subjects, while another anesthesiologist, who was unaware of classification, performed preoperative and intraoperative data collection.
All the participants received supplemented oxygen (2 - 3 L/min) via face masks. Systolic blood pressure (SBP), HR, mean arterial blood pressure (MAP), and O2 saturation (SpO2) were recorded 1 minute before (baseline) and 1, 2, 3, and 5 minutes after the induction of spinal anesthesia. Thereafter, measurements were performed in 5-minute intervals during the first 30 minutes of surgery and then every 10 minutes until the end of the surgery.
Adverse effects (ie, pruritus, nausea, vomiting, vertigo, bradycardia, or uncomfortable sensations), along with the subject’s need for ephedrine, atropine, or a rescue analgesic, were recorded. Sensory block level was assessed (based on loss of sensation to pinprick) immediately after the subject reclined and every 1 minute thereafter until she reached T6 sensory level. The measured time was recorded as the onset of complete sensory block, and at this time, surgery was allowed.
A modified Bromage scale was recorded 15 minutes after the administration of spinal anesthesia (3, no movement; 2, only able to flex the ankle and foot; 1, able to bend the knee; and 0, no paralysis and able to raise the extended leg). Hypotension (SBP ≤ 90 mmHg or > 20% decline from the baseline) was treated with 5 mg of IV ephedrine bolus; this dose was repeated as necessary to achieve an SBP of ≥ 90 mmHg. Additionally, if the mother’s HR was < 50/min, 0.5 mg of IV atropine bolus was administered.
Then, 30 IU of oxytocin was infused in 500 mL of Ringer’s solution after delivery, and a total dose of 30 mL/kg of infused Ringer’s solution continued through the end of surgery. If the parturient complained of pain at any time during surgery, 50 µg of IV fentanyl (Caspian Tamin Co., Rasht, Iran) was administered. If the analgesic was inadequate (visual analogue scale or VAS score > 4), the mentioned dose was repeated and the total rescue fentanyl dose was recorded. Upon the occurrence of nausea or vomiting, SBP was checked. In case it was ≤ 90 mmHg, treatment with 5 mg of IV ephedrine was performed; otherwise, treatment with 10 mg of metoclopramide IV bolus was selected.
The total dose of IV ephedrine and duration of surgery (from skin incision to the final skin suture) were also recorded. The newborn’s status was assessed with 1- and 5-minute Apgar scores after birth. Regression of sensory block to T10 dermatome and motor block to a modified Bromage scale of 2 were assessed every 5 minutes by an anesthesia nurse, who was blinded to the study groups in the post-anesthesia care unit (PACU). Upon pain in PACU (VAS > 4), paracetamol was infused (1 g in 100 mL of normal saline over 10 minutes) and recorded as need for the first analgesic.
The sample size was calculated with a two-tailed alpha of 0.05, power of 0.8, P1 of 47%, and P2 of 8% (frequency of ephedrine requirements in sitting and supine positions based on ref No. 5). Finally, a total of 24 women were included in each group.
Statistical analysis was performed, using SPSS version 19. Data are presented as mean ± SD, unless otherwise specified. Repeated measures analysis of variance (ANOVA) was used to analyze HR, SBP, MAP, and SpO2 measurements over time. In case of a difference, Bonferroni post-hoc test was used for comparison between the groups. Qualitative variables, as well as their associations, were analyzed, using Chi-square and Fisher’s exact tests. P value less than 0.05 was considered statistically significant.